Alpa Laboratories Share Price

Alpa Laboratories Limited is an India-based global pharmaceutical company engaged in manufacturing and selling finished pharmaceutical dosage forms. Its product range includes a variety of ethical, generic, and over the counter (OTC) drugs in various finished dosage forms for both human and veterinary use. Its human use products include capsules, such as Ampicillin Capsule IP/BP, Amoxycillin Trihydrate Capsule IP/BP, Cloxacillin Capsules IP/BP and Piroxicam Capsules IP BP; creams, gels and ointments, which include Lidocaine Hydrochloride Jelly IP/USP, Nitrofurazone Cream USP, Miconazole Cream IP/BP and Clobetasole Ointment/Cream BP; ear and eye drops, such as Benzylpenicillin Inj. IP/BP and Benzathine Penicillin Inj. IP/BP, and tablets, such as Ciprofloxacin Tablet IP / BP, Paracetamol Tablet IP/BP and Tinidazole Tablets IP/BP. Its veterinary products include boluses, such as Alpamin Bolus, Melovin-P Bolus and Alpazole Bolus, and injections, such as Atropine Inj. B.Vet.C and others.As of 25 May 2026, Alpa Laboratories share price is ₹68.00. The stock opened at ₹68.16, compared to its previous close of ₹69.16. During today's trading session, Alpa Laboratories share price moved in the range of ₹67.00 to ₹69.99, with an average price of ₹68.50 for the day. Looking at its last 52-week, the stock has touched a low of ₹67.00 and a high of ₹69.99. On the performance front, Alpa Laboratories share price has declined by 12.04% over the last six months and is down 35.10% on a year-on-year basis.

The market capitalization of Alpa Laboratories is ₹147 Crs, with a P/E ratio of 12.6 and a dividend yield of 0.00%.